| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Memorial Home Services is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Well Point is a Half Moon Bay, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PepperPointe Partnerships is a dental service organization (DSO) that provides support with non-clinical tasks to dental practices, allowing practitioners to focus on providing excellent patient care. PepperPointe seeks to redefine what it means to be ...
Synectic is a Milford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.